Stimcell Energetics (STME) Profit After Tax Growth (1y) (2012 - 2026)
Stimcell Energetics (STME) Profit After Tax Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 18.66% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 13.84% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -27.98% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 14.60% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 71.04% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 12.92% |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | 3.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 35.56% |
| Nov 30, 2025 | -122.03% |
| Aug 31, 2025 | -296.90% |
| May 31, 2025 | -88.25% |
| Feb 28, 2025 | -219.25% |
| Nov 30, 2024 | -130.41% |
| Aug 31, 2024 | 13.04% |
| May 31, 2024 | -44.21% |
| Feb 29, 2024 | 211.87% |
| Nov 30, 2023 | 57.60% |
| Aug 31, 2023 | 50.25% |
| May 31, 2023 | 52.26% |
| Feb 28, 2023 | 19.74% |
| Nov 30, 2022 | 7.55% |
| Aug 31, 2022 | 11.65% |
| May 31, 2022 | 58.70% |
| Feb 28, 2022 | 36.22% |
| Nov 30, 2021 | 21.41% |
| Aug 31, 2021 | 32.16% |
| May 31, 2021 | -150.81% |